Project objectivesEvaluation of the safety and performance of the left atrial occlusion device (Omega) in patients with non-valvular atrial fibrillation and high risk of hemorrhage |
Start and end date |
May 2022 - ongoing Approximate end December 2023 |
Project Manager |
Prof. Gian Paolo Ussia |
Coordinating institution of the project |
Eclipse Medical Ltd. |